Defy Aging Coin

Invest now for a younger you

Defy Aging Coin

Invest now for a younger you

Register Now

Defy Aging Coin

Invest now for a younger you

Register Now

Defytime has issued its own cryptocurrency to enable further anti-aging scientific research, and the completion of planned anti-aging treatment technology, to help you live a more youthful and healthier life.

Why invest in Defy Aging Coin?

Your investment will not only allow us to complete our scientific and technological goals, but also grant you exclusive priority access to our anti-aging products, and treatments when ready. Additionally, the value of your asset can be expected to increase over time as awareness of our offering grows.

  • Preferred client service. We will provide special password protected access to Defytime for preferred communication and access to products and services.
  • Defy Aging Coin can be redeemed or exchanged for Defytime’s existing products – see our telomere shop. We have been successfully selling these products for 24 months and will shortly offer a bespoke and exclusive Defytime product service, whereby products will be custom made for you.
  • Defy Aging Coin can be redeemed for our planned clinics and personalised services.

An artists impression of our planned anti-aging Nano Bath treatment clinic.

Nano Bath Anti-aging Treatment

Nanobubbles are extremely small gas bubbles that can penetrate deep into biological cells to deliver bioactive compounds. Our exclusive Nano Bath system will use a high concentration telomere water nanobubble solution to provide whole body telomere care.

Bill Andrews Premium Capsules

Bill Andrews Premium-D Aging Care Capsules will be made to order and contain a x10 stronger TAM compound. Significant improvement of cell basic strength and telomere enhancement will be achieved, rejuvenating your biological age.

Our goal is to reverse the human aging process and cure diseases linked to aging

Defytime Limited was established over 10 years ago to develop and bring to the world its technology to slow and ultimately cure aging in humans. Whilst this is a lofty goal, advancements in science are continuing to push the boundaries of knowledge and what is scientifically possible.

Defytime’s research and development activity sought to find and develop a replicable Telomerase Activation Compound (TAM) to cure TEDS (Telomerase Enzyme Deficiency Syndrome) which can then be used in its products and services. To date over USD$40 million has been spent on research and development pursuing this goal, led by Defytime director and shareholder, Dr Bill Andrews.

Bill Andrews, Ph.D.
CEO of Sierra Sciences / R&D for Defytime

Our cutting edge research is led by Dr. Bill Andrews. Dr. Andrews has worked in the biotech industry for over 35 years, focusing the last 20 years on finding ways to extend human lifespan and healthspan through the intervention of telomere shortening in human cells.

Learn more about Bill Andrews, Ph.D.

Key terms of Defy Aging Coin (DFAC)

  • 2 billion Defy Aging Coins on issue (maximum)
  • Initial coin price of USD 5 cents per coin
  • Defy Aging Coin trading commencement date is on 16th January 2021
  • Can be traded on Korean JBIT Exchange and in 2021 will be on global exchange

Valuation for Defytime Limited

Defytime Limited was valued in March 2020 using the Discounted Cash Flow (DCF) methodology at between USD$705 million and USD$958 million. The DCF took into account current trading performance together with forecast financial performance based upon the company’s business plans.1

Read the full Defytime business valuation here.

Invest now to live a more youthful and healthier life

To register your interest in purchasing Defy Aging Coin please complete the form below and we will contact you shortly.

  • This field is for validation purposes and should be left unchanged.

1 Valuation was performed by Daehyun Accounting Corporation in Seoul, South Korea. The DCF valuation methodology incorporated discount rates from 13.89% to 15.98%. Forecast results may be different to actual results due to a number of factors and such differences may be significant.